I thought about reaching out, but I think I’m about done. This is the last week of the honeymoon phase for me. I’ve been in this rollercoaster since late April and have grown tired of waiting and seeing other garbage being promoted over us. Roughly one more week for me.
Best of luck to you.
Thanks jay, forgot to mention that as well. So far the company is the only one claiming things (with only a 12 patient non peer reviewed pre-print to show for over the past 2-3 months) and they’re also only saying it on proactive TV. Something is rotten in Denmark.
We already know all that.
If what you’re saying is true, then why does he only go on that Proactive TV? Why doesn’t he try to go somewhere more mainstream? Either you promote it or you don’t. I wonder why the half-assing it?
Doesn’t matter much anymore for me, i told myself I’d give them through the first week of September before I start trimming.
Ok, done venting, I feel a tad better now.
Why do you think so high? What have we accomplished? What promotion have we done?? We have companies who probably have way less promising drugs in their bags getting on fox and CNBC. Meanwhile our ceo doesn’t say shit except to go on some jank Proactive Investors TV.
Humanigen just tweeted a few things, seems like they’ve been quiet for a while.
The second article mentions how clinical trials continue to rise in Brazil.
“Eight of these clinical trials are in the pivotal/registration stage, the final step before regulatory approval, assuming endpoints are met. These include two targeted therapies, tocilizumab and lenzilumab, as well as three small molecules, including remdesivir.”
Speaking of Nasdaq, can any of the smart folks on this board help decipher this? Every couple weeks this guy says things about the uplisting that’s way over my head.
$HGEN unlikely to provide any positive updates until they have enough authorized stock to meet the CEO's (and others) desire to convert options (CEO agreed to delay). 20-days post Notice of Action mailing August 14. How do you grant options for stock you don't have? Legal?
And, is it unusual to promote an $HGEN NASDAQ uplist when said co's finances are in disorder? Were there official deficiency notices from NASDAQ? And, where's the Board on this?
Looks like $HGEN news will be timed now for share authorization?
And, $HGEN share authorization done in compliance with Delaware law versus Nasdaq requirements - executive could receive options below min market price? Lots of stuff for lawyers to look into here. A primed insider payout coming? $HGEN
I remember hearing the ceo say in a few interviews that analysts are very interested in covering them now, but cannot until they’re listed on Nasdaq.
Also what I found to be encouraging, from one of the more recent conference calls, was the interest from some pretty big names during the Q&A portions.
I’m assuming it hasn’t started based on the NIH not officially announcing it yet.
Someone here posted this link already I believe:
Sounds like the focus is on the MABs that prevent Covid. So someone was right about it possibly hurting our price tomorrow.
I completely agree with you. I’m actually pretty confused as to what is going on, and am having a hard time coming up with a good reason as to why they’re not mentioned.
Some days I feel like the window is tightening and there are other competitors catching up, and then other days it feels like more and more of them are failing, and that this just all takes longer than I anticipated.
I guess we find out within the next week or two if this was all just a dream!